title: Proteinase K-resistant material in ARR/VRQ sheep brain affected with classical scrapie is composed mainly of VRQ prion protein.
abstract: Classical scrapie is a prion disease in sheep and goats. In sheep, susceptibility to disease is genetically influenced by single amino acid substitutions. Genetic breeding programs aimed at enrichment of arginine-171 (171R) prion protein (PrP), the so-called ARR allele, in the sheep population have been demonstrated to be effective in reducing the occurrence of classical scrapie in the field. Understanding the molecular basis for this reduced prevalence would serve the assessment of ARR adaptation. The prion formation mechanism and conversion of PrP from the normal form (PrP(C)) to the scrapie-associated form (PrP(Sc)) could play a key role in this process. Therefore, we investigated whether the ARR allele substantially contributes to scrapie prion formation in naturally infected heterozygous 171Q/R animals. Two methods were applied to brain tissue of 171Q/R heterozygous sheep with natural scrapie to determine the relative amount of the 171R PrP fraction in PrP(res), the proteinase K-resistant PrP(Sc) core. An antibody test differentiating between 171Q and 171R PrP fragments showed that PrP(res) was mostly composed of the 171Q allelotype. Furthermore, using a novel tool for prion research, endoproteinase Lys-C-digested PrP(res) yielded substantial amounts of a nonglycosylated and a monoglycosylated PrP fragment comprising codons 114 to 188. Following two-dimensional gel electrophoresis, only marginal amounts (<9%) of 171R PrP(res) were detected. Enhanced 171R(res) proteolytic susceptibility could be excluded. Thus, these data support a nearly zero contribution of 171R PrP in PrP(res) of 171R/Q field scrapie-infected animals. This is suggestive of a poor adaptation of classical scrapie to this resistance allele under these natural conditions.
authors.affiliation: Central Veterinary Institute of Wageningen UR (CVI), P.O. Box 65, 8200 AB Lelystad, The Netherlands.
authors.forename: J G
authors.initials: JG
authors.lastname: Jacobs
authors.forename: A
authors.initials: A
authors.lastname: Bossers
authors.forename: H
authors.initials: H
authors.lastname: Rezaei
authors.forename: L J M
authors.initials: LJ
authors.lastname: van Keulen
authors.forename: S
authors.initials: S
authors.lastname: McCutcheon
authors.forename: T
authors.initials: T
authors.lastname: Sklaviadis
authors.forename: I
authors.initials: I
authors.lastname: Lantier
authors.forename: P
authors.initials: P
authors.lastname: Berthon
authors.forename: F
authors.initials: F
authors.lastname: Lantier
authors.forename: F G
authors.initials: FG
authors.lastname: van Zijderveld
authors.forename: J P M
authors.initials: JP
authors.lastname: Langeveld
mesh_terms: D000483:Alleles; D000818:Animals; D015153:Blotting, Western; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D004198:Disease Susceptibility; D004351:Drug Resistance; D015180:Electrophoresis, Gel, Two-Dimensional; D019286:Endopeptidase K / Q000494:pharmacology*; D005434:Flow Cytometry; D005838:Genotype; D007124:Immunoenzyme Techniques; D011328:Prions / Q000235:genetics* / Q000378:metabolism*; D012608:Scrapie / Q000378:metabolism* / Q000473:pathology*; D012756:Sheep
chemical_list: D011328:Prions; D019286:Endopeptidase K